2020
DOI: 10.1039/c9ra10969b
|View full text |Cite
|
Sign up to set email alerts
|

The effect of size and surface ligands of iron oxide nanoparticles on blood compatibility

Abstract: Due to the unique physicochemical properties, superparamagnetic iron oxide nanoparticles (SPIONs) have attracted increased attention, which show different effects on red blood cell, plasma, platelet, C3 complement and vascular endothelial cell.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
22
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(23 citation statements)
references
References 52 publications
1
22
0
Order By: Relevance
“…When NPs are used in biomedical applications two very important characteristics must be considered: toxicity and cellular uptake (Rees et al, 2019;Santos-Rasera et al, 2019;Zhang C. et al, 2019). In fact, the biocompatibility of NPs is one of the most critical characteristics of nanoplatforms to be suitable for biomedical purposes (Elmowafy et al, 2019;Liu et al, 2020), and the NPs capability to be internalized by target cells, compared to not-target cells, is a very important goal (Emami et al, 2019;Khan et al, 2019;Khanna et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…When NPs are used in biomedical applications two very important characteristics must be considered: toxicity and cellular uptake (Rees et al, 2019;Santos-Rasera et al, 2019;Zhang C. et al, 2019). In fact, the biocompatibility of NPs is one of the most critical characteristics of nanoplatforms to be suitable for biomedical purposes (Elmowafy et al, 2019;Liu et al, 2020), and the NPs capability to be internalized by target cells, compared to not-target cells, is a very important goal (Emami et al, 2019;Khan et al, 2019;Khanna et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…[35] Hyaluronic acid-and chitosan-modified iron oxide nanoparticles did not affect platelet aggregation up to 1 mg Fe mL −1 , while polyacrylic acid-modified iron oxide nanoparticles did induce significant platelet aggregation at this concentration. [36] We then hypothesized that the observed anti-platelet effect could independently or concomitantly be attributed to (i) the trapping of fibrinogen and/or vWF in the protein corona of PVA-SPIONs which would significantly reduce the availability of these bridging plasma proteins for platelet aggregation, (ii) steric hindrance due to the presence of the SPIONs in the platelet suspensions thus interfering with platelet bridging (i.e., platelet aggregation) following their activation, and (iii) conformational change of fibrinogen in the presence of the SPIONs, thus impairing platelet bridging and subsequent aggregation (Figure 8). Indeed, fibrinogen and vWF have been detected in the adsorbed plasma protein corona of SPIONs [30] and our SPIONs have a high specific surface area (≈150 m 2 g −1 ) to support protein adsorption.…”
Section: Discussionmentioning
confidence: 99%
“…[ 34 ] Other SPION formulations have no influence on platelet functions. [ 35,36 ] Specifically, counterpart 30 nm carbon‐coated iron–carbide nanomagnets do not influence normal platelet aggregation with tested nanomagnet concentrations below 1 mg mL −1 , whether or not they are coated with PEG. [ 35 ] Hyaluronic acid‐ and chitosan‐modified iron oxide nanoparticles did not affect platelet aggregation up to 1 mg Fe mL −1 , while polyacrylic acid‐modified iron oxide nanoparticles did induce significant platelet aggregation at this concentration.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One example of these side effects was that the agents could not be administered as an intravenous bolus without risking the possible appearance of severe backache. Thus, it is imperative to evaluate biosafety before going to market [ 281 ]. Additionally, the clinically approved SPIONs were unable to differentiate between hepatocellular carcinoma and healthy liver tissue.…”
Section: Imaging Pre-clinical and Clinical Studies Of Core-shell Iron Oxide Agentsmentioning
confidence: 99%